Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-13

Clinical Trial Update: Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects [NA]

View source ↗

Summary

A completed clinical trial evaluating the effectiveness of E-prf alone and in combination with bioactive glass nanoparticles for Grade II furcation defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bioactive Glass Nanoparticles
  • E-PRF

Snippet

Sponsor: Merna Nasser Mohamed Mostafa Ibrahim Elnahas | Conditions: Furcation Defects | NA | Status: COMPLETED